Inogen (INGN) Research & Development (2013 - 2026)
Inogen (INGN) posted quarterly Research & Development of $24.6 million for Q1 2026, up 509.89% year-over-year from $4.0 million in Q1 2025, and down 70.57% quarter-over-quarter from $83.6 million in Q4 2025.
Inogen (INGN) Research & Development (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Research & Development for 14 consecutive years, with $24.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 509.89% year-over-year to $24.6 million; the TTM figure through Mar 2026 stood at $159.0 million (up 460.34% YoY), while the FY2025 annual figure was $97.7 million, up 352.07% from the prior year.
- Research & Development declined to $24.6 million in Q1 2026 per INGN's latest filing, from $83.6 million in the prior quarter.
- Across five years, Research & Development topped out at $83.6 million in Q4 2025 and bottomed at -$70.2 million in Q4 2022.
- Historically, Research & Development has averaged $7.7 million across 5 years, with a median of $5.6 million in 2024.
- Annual changes were most pronounced in 2024 — Research & Development sank 953.5% — and 2025, when it surged 623.11%.
- Inogen's Research & Development stood at -$70.2 million in 2022, then surged by 109.56% to $6.7 million in 2023, then tumbled by 953.5% to -$57.3 million in 2024, then soared by 245.9% to $83.6 million in 2025, then tumbled by 70.57% to $24.6 million in 2026.
- Business Quant data shows INGN's Research & Development at $24.6 million in Q1 2026, $83.6 million in Q4 2025, and $25.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Inogen | 152.83 Mn | 47.29 Mn | 43.27 Mn | 24.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.82 Mn |
| Mar 31, 2026 | 24.60 Mn |
| Dec 31, 2025 | 83.61 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Jun 30, 2025 | 25.39 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | -57.30 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 26.94 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | -70.22 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 28.04 Mn |
| Dec 31, 2021 | -66.53 Mn |
| Sep 30, 2021 | 3.75 Mn |